Ocular Therapeutix Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
/ 
Frequently asked questions
To buy Ocular Therapeutix Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Ocular Therapeutix Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Ocular Therapeutix Inc. is OCUL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Ocular Therapeutix Inc. has its primary listing on NASDAQ. You can trade Ocular Therapeutix Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Ocular Therapeutix Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Ocular Therapeutix Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Ocular Therapeutix Inc..